Ernest F. Karlsen

Array ( [id] => 5789666 [patent_doc_number] => 20020161237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Dehydroamino acids' [patent_app_type] => new [patent_app_number] => 09/754888 [patent_app_country] => US [patent_app_date] => 2001-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51260 [patent_no_of_claims] => 118 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20020161237.pdf [firstpage_image] =>[orig_patent_app_number] => 09754888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1507944 [patent_doc_number] => 06440986 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-08-27 [patent_title] => 'HIV Inhibiting pyrimidine derivatives' [patent_app_type] => B2 [patent_app_number] => 09/749181 [patent_app_country] => US [patent_app_date] => 2000-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15050 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 689 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/440/06440986.pdf [firstpage_image] =>[orig_patent_app_number] => 09749181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1467302 [patent_doc_number] => 06458794 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-10-01 [patent_title] => 'Potassium channel inhibitors' [patent_app_type] => B2 [patent_app_number] => 09/741085 [patent_app_country] => US [patent_app_date] => 2000-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13555 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/458/06458794.pdf [firstpage_image] =>[orig_patent_app_number] => 09741085 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6016937 [patent_doc_number] => 20020103161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'Novel heterocycles' [patent_app_type] => new [patent_app_number] => 09/740267 [patent_app_country] => US [patent_app_date] => 2000-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36129 [patent_no_of_claims] => 111 [patent_no_of_ind_claims] => 42 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20020103161.pdf [firstpage_image] =>[orig_patent_app_number] => 09740267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1378180 [patent_doc_number] => 06559151 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-05-06 [patent_title] => '6-(2-trifluoromethyl-phenyl)-triazolopyrimidines' [patent_app_type] => B2 [patent_app_number] => 09/735126 [patent_app_country] => US [patent_app_date] => 2000-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9284 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/559/06559151.pdf [firstpage_image] =>[orig_patent_app_number] => 09735126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1248458 [patent_doc_number] => 06673797 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-06 [patent_title] => 'Heterocyclic indole derivatives and mono- or diazaindole derivatives' [patent_app_type] => B1 [patent_app_number] => 09/701188 [patent_app_country] => US [patent_app_date] => 2000-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29846 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 172 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/673/06673797.pdf [firstpage_image] =>[orig_patent_app_number] => 09701188 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1281891 [patent_doc_number] => 06642237 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-04 [patent_title] => 'Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/718223 [patent_app_country] => US [patent_app_date] => 2000-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 136087 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 727 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/642/06642237.pdf [firstpage_image] =>[orig_patent_app_number] => 09718223 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1589390 [patent_doc_number] => 06482832 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-19 [patent_title] => 'Heterocyclically substituted amides, their production and their use' [patent_app_type] => B1 [patent_app_number] => 09/700453 [patent_app_country] => US [patent_app_date] => 2000-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7256 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 485 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/482/06482832.pdf [firstpage_image] =>[orig_patent_app_number] => 09700453 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1401253 [patent_doc_number] => 06538000 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-25 [patent_title] => 'Tricyclic dihydropyrimidine potassium channel openers' [patent_app_type] => B1 [patent_app_number] => 09/709923 [patent_app_country] => US [patent_app_date] => 2000-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24873 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/538/06538000.pdf [firstpage_image] =>[orig_patent_app_number] => 09709923 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1595190 [patent_doc_number] => 06384030 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-07 [patent_title] => 'Water soluble azoles as broad-spectrum antifungals' [patent_app_type] => B1 [patent_app_number] => 09/700251 [patent_app_country] => US [patent_app_date] => 2000-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26430 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 715 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/384/06384030.pdf [firstpage_image] =>[orig_patent_app_number] => 09700251 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4304628 [patent_doc_number] => 06326327 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-04 [patent_title] => 'Process for preparing MeO-Peg-protected dihydroquinine or dihydroquinidine derivatives, new dihydroquinine or dihydroquinidine derivatives and their use' [patent_app_type] => 1 [patent_app_number] => 9/699743 [patent_app_country] => US [patent_app_date] => 2000-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4103 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/326/06326327.pdf [firstpage_image] =>[orig_patent_app_number] => 699743 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1601117 [patent_doc_number] => 06476041 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-05 [patent_title] => '1,4 substituted piperidinyl NMDA/NR2B antagonists' [patent_app_type] => B1 [patent_app_number] => 09/696504 [patent_app_country] => US [patent_app_date] => 2000-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10597 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 237 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/476/06476041.pdf [firstpage_image] =>[orig_patent_app_number] => 09696504 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1589128 [patent_doc_number] => 06482774 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-19 [patent_title] => 'Substituted (4-brompyrazole-3-yl) benzazoles' [patent_app_type] => B1 [patent_app_number] => 09/673996 [patent_app_country] => US [patent_app_date] => 2000-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23261 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/482/06482774.pdf [firstpage_image] =>[orig_patent_app_number] => 09673996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1550069 [patent_doc_number] => 06346527 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-12 [patent_title] => 'Guanidine derivatives' [patent_app_type] => B1 [patent_app_number] => 09/674006 [patent_app_country] => US [patent_app_date] => 2000-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20803 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/346/06346527.pdf [firstpage_image] =>[orig_patent_app_number] => 09674006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1470306 [patent_doc_number] => 06407112 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-18 [patent_title] => 'Optically active tetrahydrobenzindole derivative' [patent_app_type] => B1 [patent_app_number] => 09/673833 [patent_app_country] => US [patent_app_date] => 2000-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12511 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/407/06407112.pdf [firstpage_image] =>[orig_patent_app_number] => 09673833 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1494581 [patent_doc_number] => 06342502 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-29 [patent_title] => 'Thieno2,3-dpyrimidine diones and their use in the treatment of reversible obstructive airways diseases' [patent_app_type] => B1 [patent_app_number] => 09/693896 [patent_app_country] => US [patent_app_date] => 2000-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26287 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 640 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/342/06342502.pdf [firstpage_image] =>[orig_patent_app_number] => 09693896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1384089 [patent_doc_number] => 06552018 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-22 [patent_title] => 'Pyrazole derivatives' [patent_app_type] => B1 [patent_app_number] => 09/688787 [patent_app_country] => US [patent_app_date] => 2000-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42305 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 574 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/552/06552018.pdf [firstpage_image] =>[orig_patent_app_number] => 09688787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1343036 [patent_doc_number] => 06586446 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-01 [patent_title] => 'Bicyclic and tricyclic amines as modulators of chemokine receptor activity' [patent_app_type] => B1 [patent_app_number] => 09/687602 [patent_app_country] => US [patent_app_date] => 2000-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48480 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 4557 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/586/06586446.pdf [firstpage_image] =>[orig_patent_app_number] => 09687602 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1417653 [patent_doc_number] => 06509328 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-21 [patent_title] => 'Glutamate receptor antagonists' [patent_app_type] => B1 [patent_app_number] => 09/687241 [patent_app_country] => US [patent_app_date] => 2000-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40256 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/509/06509328.pdf [firstpage_image] =>[orig_patent_app_number] => 09687241 [rel_patent_id] =>[rel_patent_doc_number] =>)